e-Therapeutics
高管
查看带有其 8 名主要高管的组织结构图
e-Therapeutics 搜索最多的简介
- Ali Mortazavi, Chief Executive Officer
- David Prior, Chairman of the Board
- Trevor Mervyn Jones, Director
高管在e-Therapeutics变化
- David Prior已作为Chairman of the Board加入公司 (新闻发布的2024五月27号).
创建提醒
跟踪 e-Therapeutics 的高管变动
生物技术
e-Therapeutics 拥有 2,317 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Evommune 刚刚宣布为 115 筹款数百万美元。 (公布2024十一月4号).
- AgomAb Therapeutics 刚刚宣布为 89 筹款数百万美元。 (公布2024十月29号).
- Seaport Therapeutics 刚刚宣布为 225 筹款数百万美元。 (公布2024十月25号).
生物技术 行业的其他推荐联系人
消息
e-Therapeutics 的最新新闻稿
- e-therapeutics Announces Business Updates and Interim Results
- e-therapeutics to Present at Upcoming Scientific Meetings
- Press release alerts sign up
- Results of Annual General Meeting and Appointment of Jeremy Punnett to the Board of Directors
- e-therapeutics announces completion of £28.90 million fundraise
- Pipeline update and final results for the year ended 31 January 2024
- Lord David Prior Appointed as Chair of e‑therapeutics' Board of Directors
- Last Day of Dealings on AIM
- Result of General Meeting
- Proposed Fundraise of £28.9m and Cancellation
- View more press releases Close
通过电子邮件
